Highlights
TSX: CXR       Concordia International Corp
Last Price Today's Change   Day's Range   Trading Volume
25.04   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):0
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.

  Be the first to like this.
 


 

1263  939  1421  978 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ACB 3.47+0.03 
 CNQ 40.08-0.04 
 ECA 5.56+0.04 
 VLE 0.48-0.56 
 BBD.B 1.920.00 
 POW 34.42+2.52 
 AQN 18.59+0.06 
 SU 41.90-0.15 
 CPG 5.060.00 
 MFC 25.40-0.25 
Partners & Brokers